Mavacoxib

<h2 id="references">References</h2>

<ol>
<li id="fn:1"><p>European Public Assessment Report (EPAR): Trocoxil Archived 17 March 2018 at the Wayback Machine, European Medicines Agency <a href="http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/veterinary/000132/WC500069275.pdf" target="_blank">http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/veterinary/000132/WC500069275.pdf</a> <a href="#fnref:1" class="footnote-back-ref">↩</a></p></li>
<li id="fn:2"><p>Cox SR, Lesman SP, Boucher JF, Krautmann MJ, Hummel BD, Savides M, et al. (October 2010). "The pharmacokinetics of mavacoxib, a long-acting COX-2 inhibitor, in young adult laboratory dogs". Journal of Veterinary Pharmacology and Therapeutics. 33 (5): 461–70. doi:10.1111/j.1365-2885.2010.01165.x. PMID 20840390.{{cite journal}}:  CS1 maint: overridden setting (link) <a href="/wiki/Doi_(identifier)" target="_blank">/wiki/Doi_(identifier)</a> <a href="#fnref:2" class="footnote-back-ref">↩</a></p></li>
<li id="fn:3"><p>Langreth R (23 June 2003). "The Chemical Cobbler". Forbes.{{cite news}}:  CS1 maint: overridden setting (link) <a href="https://www.forbes.com/global/2003/0623/050.html" target="_blank">https://www.forbes.com/global/2003/0623/050.html</a> <a href="#fnref:3" class="footnote-back-ref">↩</a></p></li>
<li id="fn:4"><p>"Dr. John Talley: 2001 St. Louis Awardee" (PDF). Chemical Bond. 52 (5). St. Louis Section, American Chemical Society: 2. May 2001. Archived from the original (PDF) on 15 April 2018. <a href="https://web.archive.org/web/20180415180802/http://www.stlacs.org/Bonds/2001May.pdf" target="_blank">https://web.archive.org/web/20180415180802/http://www.stlacs.org/Bonds/2001May.pdf</a> <a href="#fnref:4" class="footnote-back-ref">↩</a></p></li>
</ol>

Mavacoxib open-in-new

Mavacoxib